| [1] |
Wang H, Zhang H, Sun L, et al. Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases [J]. Am J Transl Res, 2018, 10(9): 2749-2763.
|
| [2] |
Fu J, Lee K, Chuang PY, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease [J]. Am J Physiol Renal Physiol, 2015, 308(4): F287-F297.
|
| [3] |
Jourde-Chiche N, Fakhouri F, Dou L, et al. Endothelium structure and function in kidney health and disease [J]. Nat Rev Nephrol, 2019, 15(2): 87-108.
|
| [4] |
Verma SK, Molitoris BA. Renal endothelial injury and microvascular dysfunction in acute kidney injury [J]. Semin Nephrol, 2015, 35(1): 96-107.
|
| [5] |
Yu S, Hong Q, Wang Y, et al. High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a [J]. Circ J, 2015, 79(11): 2487-2498.
|
| [6] |
Place DE, Kanneganti TD. Recent advances in inflammasome biology [J]. Curr Opin Immunol, 2018, 50: 32-38.
|
| [7] |
Schroder K, Tschopp J. The inflammasomes [J]. Cell, 2010, 140(6): 821-832.
|
| [8] |
Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation [J]. Nat Rev Microbiol, 2009, 7(2): 99-109.
|
| [9] |
Xu J, Jiang Y, Wang J, et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis [J]. Cell Death Differ, 2014, 21(8): 1229-1239.
|
| [10] |
Lin J, Cheng A, Cheng K, et al. New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease [J]. Int J Mol Sci, 2020, 21(19): 7057.
|
| [11] |
Priante G, Gianesello L, Ceol M, et al. Cell death in the kidney [J]. Int J Mol Sci, 2019, 20(14): 3598.
|
| [12] |
Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation [J]. Nature, 2011, 469(7329): 221-225.
|
| [13] |
Li Y, Yang J, Chen MH, et al. Ilexgenin A inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP/NLRP3 inflammasome activation in an AMPK dependent manner [J]. Pharmacol Res, 2015, 99: 101-115.
|
| [14] |
Yoshihara E, Masaki S, Matsuo Y, et al. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases [J]. Front Immunol, 2014, 4: 514.
|
| [15] |
Hong Q, Qi K, Feng Z, et al. Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload [J]. Cell Calcium, 2012, 51(5): 402-410.
|
| [16] |
Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals [J]. Am J Kidney Dis, 2010, 56(2): 264-272.
|
| [17] |
Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease [J]. Heart, 2013, 99(11): 759-766.
|
| [18] |
Isaka Y, Takabatake Y, Takahashi A, et al. Hyperuricemia-induced inflammasome and kidney diseases [J]. Nephrol Dial Transplant, 2016, 31(6): 890-896.
|
| [19] |
Wang G, Zuo T, Li R. The mechanism of Arhalofenate in alleviating hyperuricemia-activating PPARγ thereby reducing caspase-1 activity [J]. Drug Dev Res, 2020, 81(7): 859-866.
|
| [20] |
Rashidi M, Wicks IP, Vince JE. Inflammasomes and cell death: common pathways in microparticle diseases [J]. Trends Mol Med, 2020, 26(11): 1003-1020.
|
| [21] |
刘冰，洪权，冯哲. 高糖与高尿酸通过醛糖还原酶通路协同作用加重内皮细胞损伤[J/CD]. 中华肾病研究电子杂志，2018, 7(1): 34-38.
|
| [22] |
Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction [J]. Kidney Int, 2005, 67(5): 1739-1742.
|
| [23] |
Cruz CM, Rinna A, Forman HJ, et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages [J]. J Biol Chem, 2007, 282(5): 2871-2879.
|
| [24] |
Wang W, Wu QH, Sui Y, et al. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome [J]. Biomed Pharmacother, 2017, 86: 32-40.
|
| [25] |
Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation [J]. Nat Immunol, 2010, 11(2): 136-140.
|
| [26] |
Abais JM, Xia M, Li G, et al. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia [J]. J Biol Chem, 2014, 289(39): 27159-27168.
|
| [27] |
Wang XQ, Nigro P, World C, et al. Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2 [J]. Circ Res, 2012, 110(4): 560-568.
|